We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+29.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.47B
AUM Growth
+$451M
Cap. Flow
+$1.13B
Cap. Flow %
11.96%
Top 10 Hldgs %
21.59%
Holding
903
New
107
Increased
255
Reduced
393
Closed
103

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$51.9M
2
MRK icon
Merck
MRK
+$50.9M
3
DHR icon
Danaher
DHR
+$45.3M
4
TMO icon
Thermo Fisher Scientific
TMO
+$37.8M
5
JD icon
JD.com
JD
+$37.7M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$103M
2
BABA icon
Alibaba
BABA
+$98.6M
3
CRM icon
Salesforce
CRM
+$62.5M
4
BMY icon
Bristol-Myers Squibb
BMY
+$59.4M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$48.6M

Sector Composition

Rank Sector Weight
1 Healthcare 34.61%
2 Technology 20.94%
3 Consumer Discretionary 8.9%
4 Financials 8.59%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JOYY
851
JOYY Inc
JOYY
$3.77B
– –
-7,961
Closed -$411K
NATI
852
DELISTED
National Instruments Corp
NATI
– –
-31,811
Closed -$1.32M
BKI
853
DELISTED
Black Knight, Inc. Common Stock
BKI
– –
-28,887
Closed -$1.82M
SPPI
854
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
– –
-990,882
Closed -$3.53M
TWTR
855
DELISTED
Twitter, Inc.
TWTR
– –
-196,705
Closed -$5.93M
XENT
856
DELISTED
Intersect ENT, Inc
XENT
– –
-20,000
Closed -$487K
XEC
857
DELISTED
CIMAREX ENERGY CO
XEC
– –
-84,548
Closed -$4.34M
EV
858
DELISTED
Eaton Vance Corp.
EV
– –
-4,349
Closed -$198K
FIT
859
DELISTED
Fitbit, Inc. Class A common stock
FIT
– –
-20,000
Closed -$128K
NBL
860
DELISTED
Noble Energy, Inc.
NBL
– –
-51,069
Closed -$1.24M
WUBA
861
DELISTED
58.com Inc
WUBA
– –
-11,000
Closed -$696K
STML
862
DELISTED
Stemline Therapeutics, Inc.
STML
– –
-149,466
Closed -$1.55M
LTM
863
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
– –
-21,347
Closed -$212K
WBC
864
DELISTED
WABCO HOLDINGS INC.
WBC
– –
-132,954
Closed -$17.6M
TSG
865
DELISTED
The Stars Group Inc.
TSG
– –
-220,857
Closed -$5.63M
TGE
866
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
– –
-200,899
Closed -$4.34M
FTSV
867
DELISTED
Forty Seven, Inc. Common Stock
FTSV
– –
-64,895
Closed -$2.5M
RARX
868
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
– –
-99,523
Closed -$4.57M
OMN
869
DELISTED
OMNOVA Solutions Inc.
OMN
– –
-394,845
Closed -$3.9M
YELL
870
DELISTED
Yellow Corporation Common Stock
YELL
– –
-101,000
Closed -$252K
CY
871
DELISTED
Cypress Semiconductor
CY
– –
-478,236
Closed -$10.9M
VG
872
DELISTED
Vonage Holdings Corporation
VG
– –
-57,440
Closed -$515K
31 32 33 34
35

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2020 Portfolio in Review

As of Q2 2020, Candriam SCA held 903 positions worth $9.47B, up 5% from $9.02B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $1.13B of net new capital in Q2 2020, opening 107 new positions and adding to 255 existing holdings. Its largest new stake was JD.com: 744,410 shares worth $44.8M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $103M trimmed.

  • Candriam SCA's largest Q2 2020 buy was JD.com: 744,410 shares worth $44.8M.
  • Candriam SCA added most to Blueprint Medicines in Q2 2020, an estimated $51.9M increase.
  • Candriam SCA's biggest Q2 2020 reduction was Regeneron Pharmaceuticals, cutting an estimated $103M.
  • Candriam SCA fully exited Salesforce in Q2 2020, selling an estimated $62.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $9.47B portfolio in Q2 2020.
  • Candriam SCA opened 107 new positions and closed 103 in Q2 2020.
  • Candriam SCA's portfolio value rose 5% quarter-over-quarter to $9.47B.

Based on Candriam SCA's 13F filing for Q2 2020, filed 23 Jul 2020.